Table 2.
Statistical Fine Mapping Findings: Potentially Causal Features
| Location | Gene | SNP Weight Set | FOCUS PIPa | Colocalization |
|---|---|---|---|---|
| chr1:8412457-8877702 | RERE | YFS blood | .50 | True |
| chr1:36884051-36884179 | SNORA63 | GTEx nucleus accumbens | .70 | False |
| chr1:71861623-72748417 | NEGR1 | GTEx whole blood | 1.00 | True |
| chr1:181452685-181775921 | CACNA1E | CMC DLPFC splicing | .52 | False |
| chr1:197473878-197744623 | DENND1B | CMC DLPFC | .73 | True |
| chr2:58386377-58468515 | FANCL | CMC DLPFC splicing | .80 | True |
| chr4:41992489-42092474 | SLC30A9 | GTEx cortex | .53 | False |
| chr5:87988462-87989789 | CTC-467M3.3 | GTEx frontal cortex | .84 | True |
| chr6:99817347-99842082 | COQ3 | CMC DLPFC splicing | .97 | False |
| chr6:105584224-105617820 | BVES-AS1 | GTEx amygdala | .74 | False |
| chr7:12250867-12282993 | TMEM106B | GTEx whole blood | .61 | True |
| chr7:24836158-25021253 | OSBPL3 | GTEx pituitary | .98 | False |
| chr8:52232136-52722005 | PXDNL | CMC DLPFC | 1.00 | False |
| chr8:61297147-61429354 | RP11-163N6.2 | GTEx thyroid | .92 | False |
| chr9:126605315-126605965 | PIGFP2 | PsychENCODE DLPFC | .94 | False |
| chr11:113280318-113346111 | DRD2 | GTEx frontal cortex | .97 | False |
| chr13:53602875-53626196 | OLFM4 | CMC DLPFC | .99 | False |
| chr14:42076773-42373752 | LRFN5 | GTEx cerebellum | .50 | True |
| chr14:59971779-60043549 | CCDC175 | GTEx thyroid | .61 | True |
| chr14:64550950-64770377 | ESR2 | GTEx pituitary | .59 | True |
| chr14:75319736-75330537 | PROX2 | GTEx thyroid | .72 | True |
| chr16:72146056-72210777 | PMFBP1 | PsychENCODE DLPFC | .96 | False |
| chr17:27401933-27405875 | TIAF1 | GTEx adrenal gland | .75 | True |
Chr, chromosome; CMC, CommonMind Consortium; DLPFC, dorsolateral prefrontal cortex; GTEx, Genotype-Tissue Expression; PIP, posterior inclusion probability; SNP, single nucleotide polymorphism; YFS, Young Finns Study.
PIP estimate of causality.